Matches in Nanopublications for { ?s ?p "[Perfusion with the selective P450 epoxygenase inhibitor N-methylsulphonyl-6-(2-proparglyloxyphenyl)hexanamide (MS-PPOH) for 20 minutes before ischemia results in reduced postischemic LVDP recovery in WT hearts and abolishes the improved postischemic LVDP recovery in CYP2J2 Tr hearts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_assertion description "[Perfusion with the selective P450 epoxygenase inhibitor N-methylsulphonyl-6-(2-proparglyloxyphenyl)hexanamide (MS-PPOH) for 20 minutes before ischemia results in reduced postischemic LVDP recovery in WT hearts and abolishes the improved postischemic LVDP recovery in CYP2J2 Tr hearts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378249.RA4hZQ9JUr5L3vU8J9CT8Dy3mIfwDNCpiD_pl8Dr7V-D0130_provenance.
- NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_assertion description "[Perfusion with the selective P450 epoxygenase inhibitor N-methylsulphonyl-6-(2-proparglyloxyphenyl)hexanamide (MS-PPOH) for 20 minutes before ischemia results in reduced postischemic LVDP recovery in WT hearts and abolishes the improved postischemic LVDP recovery in CYP2J2 Tr hearts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767012.RAOxMo-8NegR0H-zu-daI9ZoAoaRYjiMLuXJnOVmt3NVI130_provenance.
- NP452203.RAiIUOI3vxyCV-x9nbwLb_b2qvrbwUfSwum3J0d9lZHZ8130_assertion description "[Perfusion with the selective P450 epoxygenase inhibitor N-methylsulphonyl-6-(2-proparglyloxyphenyl)hexanamide (MS-PPOH) for 20 minutes before ischemia results in reduced postischemic LVDP recovery in WT hearts and abolishes the improved postischemic LVDP recovery in CYP2J2 Tr hearts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452203.RAiIUOI3vxyCV-x9nbwLb_b2qvrbwUfSwum3J0d9lZHZ8130_provenance.
- NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_assertion description "[Perfusion with the selective P450 epoxygenase inhibitor N-methylsulphonyl-6-(2-proparglyloxyphenyl)hexanamide (MS-PPOH) for 20 minutes before ischemia results in reduced postischemic LVDP recovery in WT hearts and abolishes the improved postischemic LVDP recovery in CYP2J2 Tr hearts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP340964.RAyZNioAG3BmwiyDXK0tT5mA2CB2yxCBJmGX_3gv-cXkA130_provenance.